These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9158030)

  • 41. Pretransplant donor-specific helper T cell reactivity as a tool for tailoring the individual need for immunosuppression.
    van der Mast BJ; van Besouw NM; de Kuiper P; Vaessen LM; Gregoor PJ; IJzermans JN; van Gelder T; Claas FH; Weimar W
    Transplantation; 2001 Sep; 72(5):873-80. PubMed ID: 11571453
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
    Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW
    J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of skin allograft survival of a monoclonal antibody specific for a polymorphic CD3-like cell surface molecule in rhesus monkeys.
    Nooij FJ; Jonker M
    Eur J Immunol; 1987 Aug; 17(8):1089-93. PubMed ID: 3113976
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monitoring antidonor alloantibodies as a predictive assay for renal allograft tolerance/long-term observations in nonhuman primates.
    Boskovic S; Kawai T; Smith RN; Wee SL; Nadazdin O; Koyama I; Saidman S; Cardarelli F; Elias N; Sykes M; Strom T; Colvin RB; Sachs DH; Cosimi AB
    Transplantation; 2006 Sep; 82(6):819-25. PubMed ID: 17006330
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce tolerance.
    Chavin KD; Qin L; Woodward JE; Lin J; Bromberg JS
    Transplantation; 1994 Mar; 57(5):736-40. PubMed ID: 7511258
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term allograft acceptance induced by single dose anti-leukocyte common antigen (RT7) antibody in the rat.
    Ko S; Jager MD; Tsui TY; Deiwick A; Dinkel A; Rohde F; Dahlke MH; Lauth O; Wonigeit K; Schlitt HJ
    Transplantation; 2001 Apr; 71(8):1124-31. PubMed ID: 11374414
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow.
    Hale DA; Gottschalk R; Maki T; Monaco AP
    Transplantation; 1998 Feb; 65(4):473-9. PubMed ID: 9500619
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
    Margenthaler JA; Yu S; Otomo N; Lehmann M; Flye MW
    Transpl Int; 2003 Oct; 16(10):713-20. PubMed ID: 12827227
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunoregulatory role of CD8alpha in the veto effect.
    Asiedu C; Meng Y; Wang W; Huang Z; Contreras JL; George JF; Thomas JM
    Transplantation; 1999 Feb; 67(3):372-80. PubMed ID: 10030281
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phenotypic and functional analysis of T-cell recovery after anti-CD3 immunotoxin treatment for tolerance induction in rhesus macaques.
    Hubbard WJ; Moore JK; Contreras JL; Smyth CA; Chen ZW; Lobashevsky AL; Nagata K; Neville DM; Thomas JM
    Hum Immunol; 2001 May; 62(5):479-87. PubMed ID: 11334671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frequency analysis of donor-reactive cytotoxic T lymphocyte precursors in in allograft recipients. Lack of correlation with clinical outcome.
    Eberspächer ML; Otto G; Herfarth C; Kabelitz D
    Transplantation; 1994 Jun; 57(12):1746-52. PubMed ID: 8016880
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Critical requirement for graft passenger leukocytes in allograft tolerance induced by donor blood transfusion.
    Josien R; Heslan M; Brouard S; Soulillou JP; Cuturi MC
    Blood; 1998 Dec; 92(12):4539-44. PubMed ID: 9845518
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tolerance in a concordant nonhuman primate model.
    Bartholomew AM; Powelson J; Sachs DH; Bailin M; Boskovic S; Colvin R; Hong HZ; Johnson M; Kimikawa M; LeGuern A; Meehan S; Sablinski T; Wee SL; Cosimi AB
    Transplantation; 1999 Dec; 68(11):1708-16. PubMed ID: 10609947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intragraft events preceding chronic renal allograft rejection in a modified tolerance protocol.
    Shimizu A; Yamada K; Sachs DH; Colvin RB
    Kidney Int; 2000 Dec; 58(6):2546-58. PubMed ID: 11115090
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tolerance to class I-disparate renal allografts in miniature swine. Maintenance of tolerance despite induction of specific antidonor CTL responses.
    Gianello PR; Fishbein JM; Rosengard BR; Lorf T; Vitiello DM; Arn JS; Sachs DH
    Transplantation; 1995 Mar; 59(5):772-7. PubMed ID: 7886806
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model.
    Kanmaz T; Fechner JJ; Torrealba J; Kim HT; Dong Y; Oberley TD; Schultz JM; Bloom DD; Katayama M; Dar W; Markovits J; Schuler W; Hu H; Hamawy MM; Knechtle SJ
    Transplantation; 2004 Mar; 77(6):914-20. PubMed ID: 15077037
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The induction of skin xenograft tolerance in rat-to-mouse combination could be affected by DFR mediating cells and antibodies against rat bone marrow cells as well as NK cells in the cyclophosphamide-induced tolerance system.
    Nishimura Y; Eto M; Maeda T; Hiromatsu K; Nomoto K; Kong YY; Nomoto K
    Immunobiology; 1995 Aug; 193(5):420-38. PubMed ID: 8522358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
    Ruiz P; Fuller J; Sanfilippo F
    Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin.
    Sun W; Wang Q; Zhang L; Liu Y; Zhang M; Wang C; Wang J; Cao X
    Transplantation; 2003 Nov; 76(9):1351-9. PubMed ID: 14627915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.